The effect of ascorbic acid on bone cancer cells in vitro

References

• Baltriukiene, D., Kalvelyte, A., & Bukelskiene, V. (2007). Induction of apoptosis and activation of JNK and p38 MAPK pathways in deoxynivalenol-treated cell lines. Alternatives to Laboratory Animals: ATLA, 35, 53–59. Retrieved from www.ncbi.nlm.nih.gov/pubmed/17411352
   PubMed Web of Science ®Google Scholar
• Barres, L., Mota Anna, D. S., Greenberg, M., Almojaly, S., & Dziak, R. (2015). Effects of alendronate on human alveolar osteoblastic cells: Interactions with platelet-derived growth factor. International Journal of Oral Health Dentistry, 1, 2. doi:10.16966/2378-7090.108
   Google Scholar
• Belin, S., Kaya, F., Duisit, G., Giacometti, S., Ciccolini, J., & Fontés, M. (2009). Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression. PLoS One, 4, e4409. doi:10.1371/journal.pone.0004409
   PubMed Web of Science ®Google Scholar
• Benayahu, D., Shur, I., Marom, R., Meller, I., & Issakov, J. (2002). Cellular and molecular properties associated with osteosarcoma cells. Journal of Cellular Biochemistry, 84, 108–114. doi:10.1002/jcb.1270
   Web of Science ®Google Scholar
• Burotto, M., Chiou, V. L., Lee, J. M., & Kohn, E. C. (2014). The MAPK pathway across different malignancies: A new perspective. Cancer, 120, 3446–3456. doi:10.1002/cncr.28864
   PubMed Web of Science ®Google Scholar
• Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., … Levine, M. (2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proceedings of the National Academy of Sciences of the United States of America, 102, 13604–13609. doi:10.1073/pnas.0506390102
   PubMed Web of Science ®Google Scholar
• Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., … Levine, M. (2008). Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proceedings of the National Academy of Sciences, 105, 11105–11109. doi:10.1073/pnas.0506390102
   PubMed Web of Science ®Google Scholar
• Duarte, T. L., & Lunec, J. (2005). Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radical Research, 39, 671–686. doi:10.1080/10715760500104025
   PubMed Web of Science ®Google Scholar
• ElAttar, T. M. A., & Lin, H. S. (1992). Effect of vitamin C and vitamin E on prostaglandin synthesis by fibroblasts and squamous carcinoma cells. Prostaglandins, Leukotrienes and Essential Fatty Acids, 47, 253–257. doi:10.1016/0952-3278(92)90194-N
   PubMed Web of Science ®Google Scholar
• Espey, M. G., Chen, P., Chalmers, B., Drisko, J., Sun, A. Y., Levine, M., & Chen, Q. (2011). Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radical Biology and Medicine, 50, 1610–1619. doi:10.1016/j.freeradbiomed.2011.03.007
   PubMed Web of Science ®Google Scholar
• Fernandes, G., Barone, A., & Dziak, R. (2016). Effects of verapamil on bone cancer cells. Journal of Cell-Biology-&-Cell-Metabolism, 3, 13. Retrieved from http://www.heraldopenaccess.us/fulltext/Cell-Biology-&-Cell-Metabolism/Effects-of-Verapamil-on-Bone-Cancer-Cells-In-Vitro.pdf
   Google Scholar
• Fliedner, S. M., Engel, T., Lendvai, N. K., Shankavaram, U., Nölting, S., Wesley, R., … Lehnert, H. (2014). Anti-cancer potential of mapk pathway inhibition in paragangliomas—Effect of different statins on mouse pheochromocytoma cells. PloS One, 9, e97712. doi:10.1371/journal.pone.0097712
   PubMed Web of Science ®Google Scholar
• Ge, C., Xiao, G., Jiang, D., & Franceschi, R. T. (2007). Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal development. The Journal of Cell Biology, 176, 709–718. doi:10.1083/jcb.200610046
   PubMed Web of Science ®Google Scholar
• Golde, D. W. (2003). Vitamin C in cancer. Integrative Cancer Therapies, 2, 158–159. doi:10.1177/1534735403002002009
   PubMedGoogle Scholar
• Hitomi, K., & Tsukagoshi, N. (1996). Role of ascorbic acid in modulation of gene expression. In Subcellular biochemistry (pp. 41–56). Springer US. doi: 10.1007/978-1-4613-0325-1_3
   Google Scholar
• Hu, J. Z., Feng, D. Y., & Cheng, R. X. (2001). Hunan yi ke da xue xue bao= Hunan yike daxue xuebao= [Expressions of p-MAPK, cyclin D1, p53 protein and their relationship in osteosarcoma]. Bulletin of Hunan Medical University, 26, 325–327.
   Google Scholar
• Jacobs, C., Hutton, B., Ng, T., Shorr, R., & Clemons, M. (2015). Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. The Oncologist, 20, 210–223. doi:10.1634/theoncologist.2014-0381
   PubMed Web of Science ®Google Scholar
• Kubara, P. M., Kernéis-Golsteyn, S., Studény, A., Lanser, B. B., Meijer, L., & Golsteyn, R. M. (2012). Human cells enter mitosis with damaged DNA after treatment with pharmacological concentrations of genotoxic agents. Biochemical Journal, 446, 373–381. doi:10.1042/BJ20120385
   PubMed Web of Science ®Google Scholar
• Langenbach, F., & Handschel, J. (2013). Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Research & Therapy, 4, 1. doi:10.1186/scrt328
   PubMed Web of Science ®Google Scholar
• Lohmann, W. (1987). Ascorbic acid and cancer. Annals of the New York Academy of Sciences, 498, 402–417. doi:10.1111/j.1749-6632.1987.tb23777.x
   PubMed Web of Science ®Google Scholar
• Lucero, C. M., Vega, O. A., Osorio, M. M., Tapia, J. C., Antonelli, M., Stein, G. S., … Galindo, M. A. (2013). The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. Journal of Cellular Physiology, 228, 714–723. doi:10.1002/jcp.24218
   PubMed Web of Science ®Google Scholar
• Na, K. Y., Kim, Y. W., & Park, Y. K. (2012). Mitogen-activated protein kinase pathway in osteosarcoma. Pathology-Journal of the RCPA, 44, 540–546. doi:10.1097/PAT.0b013e32835803bc
   PubMed Web of Science ®Google Scholar
• Niu, N. K., Wang, Z. L., Pan, S. T., Ding, H. Q., Au, G. H., He, Z. X., … Yang, T. (2015). Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3 K/Akt/mTOR signaling pathway. Drug Design, Development and Therapy, 9, 1555. doi:10.2147/DDDT.S74197
   PubMed Web of Science ®Google Scholar
• Ohno, S., Ohno, Y., Suzuki, N., Soma, G. I., & Inoue, M. (2009). High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer. Anticancer Research, 29, 809–815. Retrieved from http://ar.iiarjournals.org/content/29/3/809.long
   PubMed Web of Science ®Google Scholar
• Padayatty, S. J., Sun, H., Wang, Y., Riordan, H. D., Hewitt, S. M., Katz, A., … Levine, M. (2004). Vitamin C pharmacokinetics: Implications for oral and intravenous use. Annals of Internal Medicine, 140, 533–537. doi:10.7326/0003-4819-140-7-200404060-00010
   PubMed Web of Science ®Google Scholar
• Pauling, L. (1980). Vitamin C therapy of advanced cancer. The New England Journal of Medicine, 302, 694–695. doi:10.1056/NEJM198003203021219
   PubMed Web of Science ®Google Scholar
• Pauling, L., Anderson, R., Banic, S., Basu, T. K., Kallistratos, G., Murata, A., … Siegel, B. V. (1981). Workshop on vitamin C in immunology and cancer. International Journal for Vitamin and Nutrition Research. Supplement= Internationale Zeitschrift fur Vitamin-und Ernahrungsforschung, 23, 209–219. Retrieved from http://europepmc.org/abstract/med/6180999
   Google Scholar
• Pauling, L., & Moertel, C. (1986). A proposition: Megadoses of vitamin C are valuable in the treatment of cancer. Nutrition Reviews, 44, 28–29. doi:10.1111/j.1753-4887.1986.tb07553.x
   PubMed Web of Science ®Google Scholar
• Schwarz, R. I., Kleinman, P., & Owens, N. (1987). Ascorbate can act as an inducer of the collagen pathway because most steps are tightly coupled. Annals of the New York Academy of Sciences, 498, 172–185. doi:10.1111/j.1749-6632.1987.tb23760.x
   PubMed Web of Science ®Google Scholar
• Takamizawa, S., Maehata, Y., Imai, K., Senoo, H., Sato, S., & Hata, R. I. (2004). Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biology International, 28, 255–265. doi:10.1016/j.cellbi.2004.01.010
   PubMed Web of Science ®Google Scholar
• Telford, W. G., Komoriya, A., & Packard, B. Z. (2002). Detection of localized caspase activity in early apoptotic cells by laser scanning cytometry. Cytometry, 47, 81–88. doi:10.1002/cyto.10052
   PubMedGoogle Scholar
• Valenti, M. T., Zanatta, M., Donatelli, L., Viviano, G., Cavallini, C., Scupoli, M. T., & Dalle Carbonare, L. U. C. A. (2014). Ascorbic acid induces either differentiation or apoptosis in MG-63 osteosarcoma lineage. Anticancer Research, 34, 1617–1627. Retrieved from http://ar.iiarjournals.org/content/34/4/1617.long
   PubMed Web of Science ®Google Scholar
• van der Reest, J., & Gottlieb, E. (2016). Anti-cancer effects of vitamin C revisited. Cell Research, 26, 269–270. doi:10.1038/cr.2016.7
   PubMed Web of Science ®Google Scholar
• Xiao, G., Jiang, D., Thomas, P., Benson, M. D., Guan, K., Karsenty, G., & Franceschi, R. T. (2000). MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. Journal of Biological Chemistry, 275, 4453–4459. doi:10.1074/jbc.275.6.4453
   PubMed Web of Science ®Google Scholar
• Yang, F., Nam, S., Zhao, R., Tian, Y., Liu, L., Horne, D. A., & Jove, R. (2013). A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling. Cancer Biology & Therapy, 14, 1024–1031. doi:10.4161/cbt.26045
   PubMed Web of Science ®Google Scholar
• Yun, J., Mullarky, E., Lu, C., Bosch, K. N., Kavalier, A., Rivera, K., … Muley, A. (2015, December). Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science, 350, 1391–1396. doi:10.1126/science.aaa5004.
   PubMed Web of Science ®Google Scholar